Compugen (CGEN) PT Lowered to $14 at Oppenheimer

February 25, 2022 5:29 AM

Oppenheimer analyst Mark Breidenbach lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $17.00) while maintaining a Outperform rating.

No results found